GSA Capital Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,170
| Closed | -$875K | – | 1892 |
|
|
2024
Q4 | $875K | Buy |
+8,170
| New | +$875K | 0.06% | 496 |
|
|
2024
Q3 | – | Sell |
-5,939
| Closed | -$500K | – | 1840 |
|
|
2024
Q2 | $500K | Buy |
5,939
+1,419
| +31% | +$119K | 0.04% | 965 |
|
|
2024
Q1 | $330K | Buy |
+4,520
| New | +$330K | 0.03% | 1158 |
|
|
2023
Q3 | – | Sell |
-3,785
| Closed | -$273K | – | 1730 |
|
|
2023
Q2 | $273K | Buy |
+3,785
| New | +$273K | 0.03% | 1103 |
|
|
2023
Q1 | – | Sell |
-20,835
| Closed | -$1.39M | – | 1722 |
|
|
2022
Q4 | $1.39M | Buy |
+20,835
| New | +$1.39M | 0.17% | 83 |
|
|
2020
Q4 | – | Sell |
-10,387
| Closed | -$618K | – | 1433 |
|
|
2020
Q3 | $618K | Buy |
+10,387
| New | +$618K | 0.1% | 281 |
|
|
2020
Q1 | – | Sell |
-8,499
| Closed | -$553K | – | 1321 |
|
|
2019
Q4 | $553K | Buy |
8,499
+3,049
| +56% | +$198K | 0.06% | 587 |
|
|
2019
Q3 | $338K | Sell |
5,450
-11,297
| -67% | -$701K | 0.05% | 806 |
|
|
2019
Q2 | $1.19M | Buy |
16,747
+4,800
| +40% | +$342K | 0.13% | 167 |
|
|
2019
Q1 | $937K | Sell |
11,947
-2,693
| -18% | -$211K | 0.09% | 323 |
|
|
2018
Q4 | $1.24M | Buy |
14,640
+5,625
| +62% | +$476K | 0.14% | 142 |
|
|
2018
Q3 | $1.54M | Sell |
9,015
-2,947
| -25% | -$505K | 0.09% | 392 |
|
|
2018
Q2 | $1.55M | Sell |
11,962
-12,245
| -51% | -$1.58M | 0.08% | 430 |
|
|
2018
Q1 | $2.49M | Buy |
24,207
+2,086
| +9% | +$215K | 0.13% | 182 |
|
|
2017
Q4 | $1.89M | Buy |
+22,121
| New | +$1.89M | 0.12% | 255 |
|
|
2016
Q2 | – | Sell |
-14,595
| Closed | -$975K | – | 1819 |
|
|
2016
Q1 | $975K | Buy |
14,595
+231
| +2% | +$15.4K | 0.06% | 554 |
|
|
2015
Q4 | $972K | Sell |
14,364
-5,834
| -29% | -$395K | 0.05% | 729 |
|
|
2015
Q3 | $1.08M | Sell |
20,198
-10,259
| -34% | -$548K | 0.05% | 581 |
|
|
2015
Q2 | $1.92M | Buy |
30,457
+16,671
| +121% | +$1.05M | 0.07% | 407 |
|
|
2015
Q1 | $663K | Buy |
+13,786
| New | +$663K | 0.03% | 1191 |
|